Dr. Annunziata on Efforts to Prevent Gynecologic Cancers
August 15th 2017Christina M. Annunziata, MD, PhD, investigator, Women's Malignancies Branch, head, Translational Genomics Section, National Cancer Institute, discusses the importance on efforts being done to prevent gynecologic cancers.
Read More
Dr. Annunziata on Olaparib and Cediranib Combination in Ovarian Cancer
March 15th 2017Christina M. Annunziata, MD, PhD, head, Translational Genomics Section, National Cancer Institute, discusses the phase II/III study of olaparib (Lynparza) and cediranib for patients with platinum-resistant ovarian cancer.
Read More